Adults with attention-deficit/hyperactivity disorder (ADHD) who use an extended-release medication are more likely to ...

Combining Adderall with other CNS stimulants, such as caffeine, can increase the risk of side effects, including elevated ...

A former South Charleston physician has been sentenced to prison after prescribing opiates and other drugs to several ...

Did you know the attention, memory, and motivation challenges associated with ADHD are rooted in biology? Learn how the brain ...

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, safety, drug interactions, dosage and administration, and place in therapy of atomoxetine in the treatment of attention-deficit ...

for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The subjects in the study were given a single 50mg dose of CTx-1301, Cingulate’s highest dosage, to determine if the medication ...

Adults with attention-deficit/hyperactivity disorder (ADHD) are more frequently presenting for diagnosis and treatment. Medication is considered to be appropriate ...

EQS-News: ABVC BioPharma, Inc. / Key word (s): Financial AiBtl BioPharma Strengthens Partnership With ABVC BioPharma, Paying $150,000 in Licensing Fees 14.01.2025 / 14:37 CET/CEST The issuer is ...

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first ...

Cingulate Inc. (NASDAQ:CING) announced the successful completion of its final FDA-required study for CTx-1301 (dexmethylphenidate) aimed at treating Attention Deficit Hyperactivity Disorder (ADHD).